Acumen Pharmaceuticals, Inc. (ABOS) vs TuHURA Biosciences, Inc. (HURA)

Acumen Pharmaceuticals, Inc. and TuHURA Biosciences, Inc. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and TuHURA Biosciences, Inc. are of similar size ($120.8M and $116.6M). Across the 10 metrics below, Acumen Pharmaceuticals, Inc. leads on 5 and TuHURA Biosciences, Inc. on 5.

Valuation

Metric ABOS HURA Biotechnology median
P/E n/m n/m 8.50
P/S 85.03 n/m 9.71
P/B 2.13 6.25 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 30.28 n/m 9.21
Earnings yield (96.45%) (30.34%) (33.15%)
Free cash flow yield (75.24%) (26.29%) (25.50%)

Profitability

Metric ABOS HURA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (120.50%) (163.84%) (56.36%)
Return on assets (72.97%) (92.31%) (48.04%)
Return on invested capital 0.00% (74.20%) 0.00%

Growth

Metric ABOS HURA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (16.96%) 47.93% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABOS HURA Biotechnology median
Debt to equity 0.55 0.47 0.00
Current ratio 2.47 0.18 4.72
Net debt to EBITDA 0.69 0.12 0.96

Dividend

Metric ABOS HURA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABOS HURA Biotechnology median
Market cap 120.77m 116.62m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack